Geets Xavier, Daisne Jean-Francois, Tomsej Milan, Duprez Thierry, Lonneux Max, Grégoire Vincent
Department of Radiation Oncology and Head and Neck Oncology Program, Université Catholique de Louvain, Brussels, Belgium.
Radiother Oncol. 2006 Mar;78(3):291-7. doi: 10.1016/j.radonc.2006.01.006. Epub 2006 Feb 24.
It has been shown that the use of pre-treatment FDG-PET impacted on the GTV delineation of pharyngo-laryngeal tumors. The goals of this study were to evaluate (1) the impact of FDG-PET GTV on dose distribution, and (2) the impact of per-treatment re-imaging on target volume delineation and dose distribution.
Eighteen patients with squamous cell carcinoma of the oropharynx or larynx/hypopharynx were treated with curative intent by forward planning IMRT. Prior to treatment and on average after a dose of 46 Gy, all patients underwent contrast-enhanced CT, MRI and FDG-PET. After coregistration, GTVs were delineated manually on CT and MRI and automatically on FDG-PET. From these volumes, CTVs and PTVs were derived using consistent guidelines. Planning was performed using conformal radiotherapy.
GTVs, CTVs and PTVs based on pre-treatment FDG-PET were significantly smaller than those based on pre-treatment CT. Such difference in target volumes (TV) translated into a significant reduction in the irradiated volumes (reduction of 13 and 18% of the V50 and V95, respectively), Dmean to ipsilateral parotids (30.7 and 38.6% for FDG-PET and CT based plans, respectively) and to controlateral parotids (11.2 and 14.4% for FDG-PET and CT based plans, respectively). TVs based on per-treatment CT or MRI were also significantly smaller compared to those delineated from pre-treatment CT. Volumes delineated with MRI were significantly smaller than those delineated with CT. Due to radiotherapy-induced peri-tumoral inflammation, automatic delineation of FDG-PET GTV could not be performed. Such reductions in TVs translated into a reduction of the irradiated volumes compared to pre-treatment CT planning (reduction for V50 of 19 and 32%, and for V95 of 22 and 40%, for CT and MRI, respectively); Dmean to the ipsilateral parotids were also reduced (ipsilateral parotid Dmean of 20.4% for CT and of 20.1% for MRI compared to 24.7% for pre-treatment CT).
The use of pre-treatment FDG-PET and per-treatment CT or MRI significantly impacts on the delineation of TVs in pharyngo-laryngeal SCC, translating into more normal tissue sparing after conformal radiotherapy planning.
已表明治疗前使用氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)会影响咽喉部肿瘤的大体肿瘤体积(GTV)勾画。本研究的目的是评估:(1)FDG-PET GTV对剂量分布的影响;(2)每次治疗前重新成像对靶区体积勾画和剂量分布的影响。
18例口咽或喉/下咽鳞状细胞癌患者接受了旨在根治的正向计划调强放射治疗(IMRT)。治疗前及平均给予46 Gy剂量后,所有患者均接受了增强CT、MRI和FDG-PET检查。图像配准后,在CT和MRI上手动勾画GTV,在FDG-PET上自动勾画GTV。根据这些体积,使用一致的指南得出临床靶体积(CTV)和计划靶体积(PTV)。采用适形放疗进行计划制定。
基于治疗前FDG-PET的GTV、CTV和PTV明显小于基于治疗前CT的相应体积。靶区体积(TV)的这种差异转化为照射体积的显著减少(V50和V95分别减少13%和18%),同侧腮腺的平均剂量(基于FDG-PET和CT的计划分别为30.7%和38.6%)以及对侧腮腺的平均剂量(基于FDG-PET和CT的计划分别为11.2%和14.4%)。基于每次治疗时的CT或MRI的TV也明显小于根据治疗前CT勾画的TV。用MRI勾画的体积明显小于用CT勾画的体积。由于放疗引起的肿瘤周围炎症,无法对FDG-PET GTV进行自动勾画。与治疗前CT计划相比,TV的这种减少转化为照射体积的减少(CT和MRI的V50分别减少19%和32%,V95分别减少22%和40%);同侧腮腺的平均剂量也降低了(与治疗前CT的24.7%相比,CT的同侧腮腺平均剂量为20.4%,MRI为20.1%)。
治疗前使用FDG-PET以及每次治疗时使用CT或MRI对咽喉部鳞状细胞癌(SCC)的TV勾画有显著影响,在适形放疗计划后可使更多正常组织得到保护。